CNS Pharmaceuticals
CNSP
CNSP
5 hedge funds and large institutions have $234K invested in CNS Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$53K | |
| 2 | +$50.3K | |
| 3 | +$49K | |
| 4 |
FWA
FSM Wealth Advisors
Cleveland,
Ohio
|
+$37.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$36K |
Top Sellers
| 1 | -$124K | |
| 2 | -$27K | |
| 3 | -$13.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12K |
| 5 |
VF
Virtu Financial
New York
|
-$11K |